Registrars: | Capita Registrars |
CEO: | Suzanne Dilly |
CFO: | Gerald Desler |
Non-Executive Chairman: | Kevin Cox |
Non-Executive Director & Chairman: | Martin Gouldstone |
Non-Executive Dir: | Martin Lampshire, Adrian de Courcey |
Address: | Stonebridge House, Chelmsford Road, Hatfield Heath, United Kingdom, CM22 7BD |
Website: | http://www.valirx.com |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BLH13C52 |
Currency | UK Pounds |
Share Price | 3.45p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 14.13 |
52 Week Low | 3.41 |
Volume | 29,524 |
Shares Issued | 132.35m |
Market Cap | £4.57m |
RiskGrade | 435 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
You are here: research